Project Grant R21AI180738
Award Date
8/26/24
Completion Date
6/30/26
Dollars Obligated
$390K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Moscow, ID 83844, USA
Similar Awards
This federal Project Grant award of $130,950 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at the University of Idaho to understand the developmental cycle of Chlamydia bacteria at the single-cell level. The key objectives are to: 1) Develop a CRISPR-based knockdown screen to assess the role of essential genes in regulating Chlamydia cell type function and the developmental...
This is a Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research program (CFDA 93.855). The $207,225 award supports research to investigate how the bacterium Chlamydia trachomatis manipulates cellular pathways, specifically the PICALM protein, to maintain a "silent" infection within the host cell. The goal is to better understand how Chlamydia utilizes host cell nutrient trafficking to promote its...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $782,795 to the University of Tennessee Health Science Center in Memphis, TN to conduct research on the regulation of cell division in the bacterial pathogen Chlamydia trachomatis. The research aims to define the molecular mechanisms that regulate the unique polarized division process of Chlamydia, which lacks several proteins essential for...
This Project Grant award, ID R21AI178108, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $617,000 grant, awarded on August 21, 2024, supports research led by The University of Kentucky Research Foundation to investigate the role of putative cytotoxins in Chlamydia infection. The researchers aim to apply genetic and biochemical approaches to delineate the molecular functions of these...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research, provides $423,500.00 to The University of Kentucky Research Foundation to investigate the role(s) of chlamydial polymorphic membrane proteins (PMPs) during infection with Chlamydia trachomatis. The research aims to delineate the specific function(s) of the PmpI protein during different stages of the chlamydial developmental cycle, as...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $226,204 to the University of Maryland, Baltimore to investigate the vaginal microbiome and immune response factors that contribute to the spontaneous clearance of Chlamydia trachomatis (CT) infections in women. The key objectives are to: (1) evaluate species- and strain-specific vaginal bacterial growth rates, (2)...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $220,224.00 to the University of Chicago to computationally investigate key morphological transitions in the HIV-1 life cycle. The research aims to improve understanding of the assembly and disassembly processes involved in HIV-1 infection, including virion budding, viral core maturation, and capsid uncoating. This...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $569,210 Project Grant to the University of Colorado Boulder. The five-year grant, effective February 1, 2025, supports research to structurally and functionally characterize three proteins responsible for antimicrobial resistance, screen for probes to define inhibitory strategies, and develop a platform to quantitatively test the impact of target...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $218,767.00 to the University of Washington to conduct a single-cell transcriptional atlas study of Giardia encystation. The research aims to build an atlas of gene expression during the Giardia cell cycle (Aim 1) and differentiation into cyst forms (Aim 2). This work will deepen the understanding of the encystation...